CVE-2026-50034

Health data disclosure via cleartext BLE traffic

Published Jun 18, 2026 · Updated Jun 18, 2026

Cleartext transmission in Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT 0x0110_v1.1.0 allows attackers to read glucose values. The device transmits health-related measurement data over its BLE link without protecting the content from passive listeners. Physical proximity within BLE range is required; no authentication or user interaction is needed, and the reported impact is limited to disclosure.

CVSS severity7.1
High
EPSS probability0.21%
Next 30 days · Sep 16, 2026
Known exploitationUnconfirmed
Based on sourced intelligence
Hinoki checkNot available
Coverage for this vulnerability

See if you're affected

Explore vulnerability checks for your environment with Hinoki.

Book a demo

Summary

What happened

Cleartext transmission in Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT 0x0110_v1.1.0 allows attackers to read glucose values. The device transmits health-related measurement data over its BLE link without protecting the content from passive listeners. Physical proximity within BLE range is required; no authentication or user interaction is needed, and the reported impact is limited to disclosure.

The record

CVE
CVE-2026-50034
Published
Jun 18, 2026
Updated
Jun 18, 2026
Vendor
Apollo Pharmacy
Product
Blood Glucose Monitoring System APG-01 BT
Classifications
CWE-319, CAPEC-117, T1040
Attack vector
adjacent
Privileges
unauthenticated

Timeline

How it unfolded

  1. Jun 18, 2026CVE publishedPublication date reported by the CVE source.
  2. Jun 18, 2026Record updatedLatest update available in the CVE record.

Exploitability

Present is not the same as exploitable

Compare your product and version with the public record. A matching version still requires validation against your environment.

Is a vulnerable build present?

Compare these published version ranges with your installed build and any vendor patches.

  1. Affected versionversion=0x0110_v1.1.0

What conditions does exploitation require?

Attack vectoradjacent
Required privilegesunauthenticated

What is affected?

Apollo Pharmacy · Blood Glucose Monitoring System APG-01 BTversion=0x0110_v1.1.0

Published CVSS scores

7.1ICS-CERTCVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N
6.5ICS-CERTCVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

CVSS describes severity. EPSS estimates exploitation probability.

Attacks

What attackers are doing with it

Daily unique IPs observed by Shadowserver honeypots for known exploited vulnerabilities (KEVs). Missing observations do not establish an absence of attacks.

Daily unique IPsNo honeypot observations are available for this CVE in the selected window.

No observations available

Sep 10, 2026Sep 16, 2026
Latest reporting daySep 16, 2026
Latest daily unique IPsUnavailable
Prior 30-day averageUnavailable
SourceShadowserver honeypots (KEV)
Vectoradjacent
Privilegesunauthenticated
Known exploitationUnconfirmed
Public exploitUnconfirmed

Weakness, pattern, technique

CWE-319Cleartext Transmission of Sensitive Information
CAPEC-117Interception
T1040Network Sniffing

Public exploit references

No public exploit references are available in this record.

Labels summarize the accepted research assessment. They do not indicate a test against your environment.

Technologies

Your stack

See the directory against your own environment.

Your stack

Check the software in your environment

Book a demo to see how Hinoki identifies affected software and validates exploitability in your environment.

Book a demo